August 14, 2020
Article
The challenges of making formulary and clinical decisions based on regulatory studies are significant and the need for real-world clinical experience is increasingly important.
July 01, 2019
The global emergence of antimicrobial resistance among gram-negative species is a major public health concern.
Oral Sabizabulin Reduces COVID-19 Deaths in High-Risk Adults
Pneumonic Plague in an Era of COVID-19
FDA: Pharmacists Can Prescribe Paxlovid to Eligible Patients
Utilizing Global Surveillance to Develop a Syphilis Vaccine